Researchers at the University of California, Davis have developed a scalable and sustainable method using edible fungal pellets as microcarriers to grow animal cells for cultivated meat production.

Researchers at the University of California, Davis have developed a machine learning system that accurately detects and estimates retinal inflammation severity in uveitis patients using non-invasive OCT B-scan images.

Researchers at the University of California, Davis have developed a system and method for accurately extracting fetal photoplethysmography information from mixed maternal-fetal signals obtained non-invasively through the maternal abdomen.

Researchers at the University of California, Davis have developed technology that enables enhanced growth and colonization of beneficial gut bacteria through bacterial expression of heterologous alpha-fucosidases which target human milk oligosaccharides (HMOs), promoting a healthy gut microbiome.

Researchers at the University of California, Davis have developed alacto-oligosaccharide (GOS) formulations selectively promote growth of beneficial Bifidobacteria species by tailoring oligosaccharide chain lengths.

Researchers at the University of California, Davis have developed a technology that enables rapid, reversible, and opposite-direction optical switching in the mid-infrared range using single crystalline halide perovskite materials activated by either light or heat.

Researchers at the University of California, Davis have developed recombinant fusion protein compositions that inhibit pathological angiogenesis by targeting VEGF165-KDR interactions to treat cancers and related diseases.

Researchers at the University of California, Davis have developed methods that combine immunotherapeutic agents with dual inhibitors to enhance cancer treatment efficacy and prolong patient survival.